2-ethyl-8-methyl-2,8-diazaspiro(4,5)decane-1,3-dione has been researched along with Behavior Disorders in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (50.00) | 18.7374 |
| 1990's | 1 (50.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Bahro, M; Berger, M; Gann, H; Hohagen, F; Lis, S; Riemann, D; Stadmüller, G | 1 |
| Berger, M; Höchli, D; Riemann, D; Spiegel, R | 1 |
1 trial(s) available for 2-ethyl-8-methyl-2,8-diazaspiro(4,5)decane-1,3-dione and Behavior Disorders
| Article | Year |
|---|---|
Cholinergic neurotransmission, REM sleep and depression.
Topics: Adolescent; Adult; Aged; Alzheimer Disease; Brain Stem; Cholinergic Agonists; Cholinergic Fibers; Depressive Disorder; Dose-Response Relationship, Drug; Double-Blind Method; Female; Galantamine; Humans; Male; Mental Disorders; Middle Aged; Parasympathomimetics; Physostigmine; Polysomnography; Reaction Time; Receptors, Muscarinic; Sleep Stages; Sleep Wake Disorders; Sleep, REM; Succinimides; Synaptic Transmission; Tacrine | 1994 |
1 other study(ies) available for 2-ethyl-8-methyl-2,8-diazaspiro(4,5)decane-1,3-dione and Behavior Disorders
| Article | Year |
|---|---|
The cholinergic rapid eye movement sleep induction test with RS-86. State or trait marker of depression?
Topics: Adolescent; Adult; Depressive Disorder; Diagnosis, Differential; Female; Half-Life; Humans; Male; Mental Disorders; Middle Aged; Personality Inventory; Receptors, Cholinergic; Sleep; Sleep, REM; Succinimides | 1989 |